Thomas Whalen

Thomas Whalen is an accomplished sales professional with extensive experience in the pharmaceutical and medical device industries. Currently serving as a Specialty Account Manager at Axsome Therapeutics, Inc., Thomas focuses on CNS and rare diseases, engaging with pulmonologists, neurologists, sleep specialists, and psychiatric offices across multiple states. Previous roles include positions at Jazz Pharmaceuticals, where Thomas launched the company's first product during the pandemic, Biohaven Pharmaceuticals, where Thomas was instrumental in promoting the innovative Nurtec ODT, and Takeda, recognized as the 2018 Cresset Award winner for exceptional sales performance. Thomas has demonstrated a consistent ability to exceed sales goals across various companies and therapeutic areas, supported by an educational background in Business Administration and Management from Northeastern University.